Long-term outcome of photodynamic therapy with systemic chemotherapy compared to photodynamic therapy alone in patients with advanced hilar cholangiocarcinoma

Gut and Liver

Volumn 8, Issue 3, 2014, Pages 318-323

  Hong, MiJin ^a   Cheon, Young Koog ^a   Lee, Eung Jun ^a   Lee, Tae Yoon ^a   Shim, Chan Sup ^a  

^a Konkuk University School of Medicine   (South Korea)

Author keywords

Cholangiocarcinoma; Drug therapy; Photochemotherapy

Indexed keywords

BILIRUBIN; CISPLATIN; GEMCITABINE; HEMATOPORPHYRIN DERIVATIVE; PHOTOFRIN; ANTINEOPLASTIC AGENT; DEOXYCYTIDINE; FLUOROURACIL;

ADULT; AGED; ARTICLE; BILE DUCT CARCINOMA; BILIRUBIN BLOOD LEVEL; CANCER CHEMOTHERAPY; CANCER PROGNOSIS; CANCER SURVIVAL; CHOLANGITIS; CONTROLLED STUDY; FEMALE; HUMAN; LIVER ABSCESS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MULTIPLE CYCLE TREATMENT; PHOTODYNAMIC THERAPY; PHOTOTOXICITY; TREATMENT OUTCOME; ANALOGS AND DERIVATIVES; BILE DUCT NEOPLASMS; CHOLANGIOCARCINOMA; COMPARATIVE STUDY; ENDOSCOPIC RETROGRADE CHOLANGIOPANCREATOGRAPHY; EVALUATION STUDY; INTRAHEPATIC BILE DUCT; KAPLAN MEIER METHOD; MIDDLE AGED; MORTALITY; MULTIMODALITY CANCER THERAPY; PHOTOCHEMOTHERAPY; PROCEDURES;

ADULT; AGED; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; BILE DUCT NEOPLASMS; BILE DUCTS, INTRAHEPATIC; CHOLANGIOCARCINOMA; CHOLANGIOPANCREATOGRAPHY, ENDOSCOPIC RETROGRADE; CISPLATIN; COMBINED MODALITY THERAPY; DEOXYCYTIDINE; FEMALE; FLUOROURACIL; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; PHOTOCHEMOTHERAPY; TREATMENT OUTCOME;

EID: 84901231137     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2014.8.3.318     Document Type: Article

References (24)

1. Carriaga MT, Henson DE. Liver, gallbladder, extrahepatic bile ducts, and pancreas. Cancer 1995;75(1 Suppl):171-190.
2. Rea DJ, Munoz-Juarez M, Farnell MB, et al. Major hepatic resection for hilar cholangiocarcinoma: analysis of 46 patients. Arch Surg 2004;139:514-523.
3. Jarnagin WR, Fong Y, DeMatteo RP, et al. Staging, resectability, and outcome in 225 patients with hilar cholangiocarcinoma. Ann Surg 2001;234:507-517.
4. Jang JY, Kim SW, Park DJ, et al. Actual long-term outcome of extrahepatic bile duct cancer after surgical resection. Ann Surg 2005;241:77-84. (Pubitemid 40040995)
5. Klempnauer J, Ridder GJ, Werner M, Weimann A, Pichlmayr R. What constitutes long-term survival after surgery for hilar cholangiocarcinoma? Cancer 1997;79:26-34. (Pubitemid 26425504)
6. Cheon YK. The role of photodynamic therapy for hilar cholangiocarcinoma. Korean J Intern Med 2010;25:345-352.
7. Blumgart LH, Stain SC. Surgical treatment of cholangiocarcinoma. Cancer Treat Res 1994;69:75-96.
8. Verbeek PC, Van der Heyde MN, Ramsoekh T, Bosma A. Clinical significance of implantation metastases after surgical treatment of cholangiocarcinoma. Semin Liver Dis 1990;10:142-144. (Pubitemid 20214610)
9. Pichlmayr R, Lamesch P, Weimann A, Tusch G, Ringe B. Surgical treatment of cholangiocellular carcinoma. World J Surg 1995;19:83-88.
10. Zoepf T, Jakobs R, Arnold JC, Apel D, Riemann JF. Palliation of nonresectable bile duct cancer: improved survival after photodynamic therapy. Am J Gastroenterol 2005;100:2426-2430.
11. Ortner ME, Caca K, Berr F, et al. Successful photodynamic therapy for nonresectable cholangiocarcinoma: a randomized prospective study. Gastroenterology 2003;125:1355-1363. (Pubitemid 37409755)
12. Valle J, Wasan H, Palmer DH, et al. Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 2010;362:1273-1281.
13. Burke EC, Jarnagin WR, Hochwald SN, Pisters PW, Fong Y, Blumgart LH. Hilar cholangiocarcinoma: patterns of spread, the importance of hepatic resection for curative operation, and a presurgical clinical staging system. Ann Surg 1998;228:385-394. (Pubitemid 30191701)
14. Vauthey JN, Blumgart LH. Recent advances in the management of cholangiocarcinomas. Semin Liver Dis 1994;14:109-114. (Pubitemid 24153079)
15. Pahernik SA, Dellian M, Berr F, Tannapfel A, Wittekind C, Goetz AE. Distribution and pharmacokinetics of Photofrin in human bile duct cancer. J Photochem Photobiol B 1998;47:58-62. (Pubitemid 29060525)
16. Davids PH, Groen AK, Rauws EA, Tytgat GN, Huibregtse K. Randomised trial of self-expanding metal stents versus polyethylene stents for distal malignant biliary obstruction. Lancet 1992;340:1488-1492.
17. Bowling TE, Galbraith SM, Hatfield AR, Solano J, Spittle MF. A retrospective comparison of endoscopic stenting alone with stenting and radiotherapy in non-resectable cholangiocarcinoma. Gut 1996;39:852-855. (Pubitemid 27049089)
18. Ducreux M, Liguory C, Lefebvre JF, et al. Management of malignant hilar biliary obstruction by endoscopy: results and prognostic factors. Dig Dis Sci 1992;37:778-783.
19. Molt P, Hopfan S, Watson RC, Botet JF, Brennan MF. Intraluminal radiation therapy in the management of malignant biliary obstruction. Cancer 1986;57:536-544. (Pubitemid 16164606)
20. Berr F, Wiedmann M, Tannapfel A, et al. Photodynamic therapy for advanced bile duct cancer: evidence for improved palliation and extended survival. Hepatology 2000;31:291-298. (Pubitemid 30078590)
21. Shim CS, Cheon YK, Cha SW, et al. Prospective study of the effectiveness of percutaneous transhepatic photodynamic therapy for advanced bile duct cancer and the role of intraductal ultrasonography in response assessment. Endoscopy 2005;37:425-433. (Pubitemid 40668207)
22. Farley DR, Weaver AL, Nagorney DM. "Natural history" of unresected cholangiocarcinoma: patient outcome after noncurative intervention. Mayo Clin Proc 1995;70:425-429.
23. Polydorou AA, Cairns SR, Dowsett JF, et al. Palliation of proximal malignant biliary obstruction by endoscopic endoprosthesis insertion. Gut 1991;32:685-689.
24. Chang WH, Kortan P, Haber GB. Outcome in patients with bifurcation tumors who undergo unilateral versus bilateral hepatic duct drainage. Gastrointest Endosc 1998;47:354-362. (Pubitemid 28237504)